Cargando…
Sero-epidemiological study of SARS-CoV-2 infection among healthcare personnel in a healthcare department()()
OBJECTIVE: Estimate IgG antibody prevalence against SARS-CoV-2 in healthcare personnel (HCP) of a healthcare department (HD). METHOD: Prevalence study. The presence of IgG antibodies against SARS-CoV-2 was determined in HCP of the HD. Enzyme linked immunosorbent assays (ELISA) tests were used. Field...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126087/ https://www.ncbi.nlm.nih.gov/pubmed/34353507 http://dx.doi.org/10.1016/j.eimce.2021.05.008 |
_version_ | 1783693698281766912 |
---|---|
author | Gras-Valentí, Paula Chico-Sánchez, Pablo Algado-Sellés, Natividad Gimeno-Gascón, María Adelina Mora-Muriel, Juan Gabriel Jiménez-Sepúlveda, Natali Juliet Gómez-Sotero, Isel Lilibeth Montiel-Higuero, Inés Sánchez-Payá, José Rodríguez-Díaz, Juan Carlos |
author_facet | Gras-Valentí, Paula Chico-Sánchez, Pablo Algado-Sellés, Natividad Gimeno-Gascón, María Adelina Mora-Muriel, Juan Gabriel Jiménez-Sepúlveda, Natali Juliet Gómez-Sotero, Isel Lilibeth Montiel-Higuero, Inés Sánchez-Payá, José Rodríguez-Díaz, Juan Carlos |
author_sort | Gras-Valentí, Paula |
collection | PubMed |
description | OBJECTIVE: Estimate IgG antibody prevalence against SARS-CoV-2 in healthcare personnel (HCP) of a healthcare department (HD). METHOD: Prevalence study. The presence of IgG antibodies against SARS-CoV-2 was determined in HCP of the HD. Enzyme linked immunosorbent assays (ELISA) tests were used. Field work took place from April 24, 2020 to May 8, 2020. The age, sex, occupation (physician, nurse, etc.) and the work area (Primary Care, Emergency Room, etc.) were gathered. The IgG antibody prevalence was then calculated with its 95% confidence interval (95% CI). To study the association between HCP characteristics and the presence IgG the Chi Square test was used, and to study the magnitude of association, the Odds Ratio (95% CI) was calculated. RESULTS: Of the 4813 HCP in the HD, 4179 (87,1%) participated. Of these, 73,3% (3065) were women and 26,7% (1114) men. The global prevalence of IgG antibodies against SARS-CoV-2 was 6,6% (95% CI: 5,8–7,3). There were statistically significant differences depending on the occupation, from 8,7% (95% CI: 6,9-10,6) on medics down to 3,2% (95% CI: 1,0-8,0) on personnel not associated with health care. The other characteristics did not associate significantly to antibody presence against SARS-CoV-2. CONCLUSION: The SARS-CoV-2 infection frequency in HCP is similar to the estimated in the general population for big cities in Spain. This highlights the effectiveness of the infection control and prevention programme in this healthcare department targeted at healthcare personnel. |
format | Online Article Text |
id | pubmed-8126087 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81260872021-05-17 Sero-epidemiological study of SARS-CoV-2 infection among healthcare personnel in a healthcare department()() Gras-Valentí, Paula Chico-Sánchez, Pablo Algado-Sellés, Natividad Gimeno-Gascón, María Adelina Mora-Muriel, Juan Gabriel Jiménez-Sepúlveda, Natali Juliet Gómez-Sotero, Isel Lilibeth Montiel-Higuero, Inés Sánchez-Payá, José Rodríguez-Díaz, Juan Carlos Enferm Infecc Microbiol Clin (Engl Ed) Original Article OBJECTIVE: Estimate IgG antibody prevalence against SARS-CoV-2 in healthcare personnel (HCP) of a healthcare department (HD). METHOD: Prevalence study. The presence of IgG antibodies against SARS-CoV-2 was determined in HCP of the HD. Enzyme linked immunosorbent assays (ELISA) tests were used. Field work took place from April 24, 2020 to May 8, 2020. The age, sex, occupation (physician, nurse, etc.) and the work area (Primary Care, Emergency Room, etc.) were gathered. The IgG antibody prevalence was then calculated with its 95% confidence interval (95% CI). To study the association between HCP characteristics and the presence IgG the Chi Square test was used, and to study the magnitude of association, the Odds Ratio (95% CI) was calculated. RESULTS: Of the 4813 HCP in the HD, 4179 (87,1%) participated. Of these, 73,3% (3065) were women and 26,7% (1114) men. The global prevalence of IgG antibodies against SARS-CoV-2 was 6,6% (95% CI: 5,8–7,3). There were statistically significant differences depending on the occupation, from 8,7% (95% CI: 6,9-10,6) on medics down to 3,2% (95% CI: 1,0-8,0) on personnel not associated with health care. The other characteristics did not associate significantly to antibody presence against SARS-CoV-2. CONCLUSION: The SARS-CoV-2 infection frequency in HCP is similar to the estimated in the general population for big cities in Spain. This highlights the effectiveness of the infection control and prevention programme in this healthcare department targeted at healthcare personnel. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. 2021 2021-05-16 /pmc/articles/PMC8126087/ /pubmed/34353507 http://dx.doi.org/10.1016/j.eimce.2021.05.008 Text en © 2020 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Gras-Valentí, Paula Chico-Sánchez, Pablo Algado-Sellés, Natividad Gimeno-Gascón, María Adelina Mora-Muriel, Juan Gabriel Jiménez-Sepúlveda, Natali Juliet Gómez-Sotero, Isel Lilibeth Montiel-Higuero, Inés Sánchez-Payá, José Rodríguez-Díaz, Juan Carlos Sero-epidemiological study of SARS-CoV-2 infection among healthcare personnel in a healthcare department()() |
title | Sero-epidemiological study of SARS-CoV-2 infection among healthcare personnel in a healthcare department()() |
title_full | Sero-epidemiological study of SARS-CoV-2 infection among healthcare personnel in a healthcare department()() |
title_fullStr | Sero-epidemiological study of SARS-CoV-2 infection among healthcare personnel in a healthcare department()() |
title_full_unstemmed | Sero-epidemiological study of SARS-CoV-2 infection among healthcare personnel in a healthcare department()() |
title_short | Sero-epidemiological study of SARS-CoV-2 infection among healthcare personnel in a healthcare department()() |
title_sort | sero-epidemiological study of sars-cov-2 infection among healthcare personnel in a healthcare department()() |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126087/ https://www.ncbi.nlm.nih.gov/pubmed/34353507 http://dx.doi.org/10.1016/j.eimce.2021.05.008 |
work_keys_str_mv | AT grasvalentipaula seroepidemiologicalstudyofsarscov2infectionamonghealthcarepersonnelinahealthcaredepartment AT chicosanchezpablo seroepidemiologicalstudyofsarscov2infectionamonghealthcarepersonnelinahealthcaredepartment AT algadosellesnatividad seroepidemiologicalstudyofsarscov2infectionamonghealthcarepersonnelinahealthcaredepartment AT gimenogasconmariaadelina seroepidemiologicalstudyofsarscov2infectionamonghealthcarepersonnelinahealthcaredepartment AT moramurieljuangabriel seroepidemiologicalstudyofsarscov2infectionamonghealthcarepersonnelinahealthcaredepartment AT jimenezsepulvedanatalijuliet seroepidemiologicalstudyofsarscov2infectionamonghealthcarepersonnelinahealthcaredepartment AT gomezsoteroisellilibeth seroepidemiologicalstudyofsarscov2infectionamonghealthcarepersonnelinahealthcaredepartment AT montielhigueroines seroepidemiologicalstudyofsarscov2infectionamonghealthcarepersonnelinahealthcaredepartment AT sanchezpayajose seroepidemiologicalstudyofsarscov2infectionamonghealthcarepersonnelinahealthcaredepartment AT rodriguezdiazjuancarlos seroepidemiologicalstudyofsarscov2infectionamonghealthcarepersonnelinahealthcaredepartment AT seroepidemiologicalstudyofsarscov2infectionamonghealthcarepersonnelinahealthcaredepartment AT seroepidemiologicalstudyofsarscov2infectionamonghealthcarepersonnelinahealthcaredepartment |